Atnaujinta: 2024.07.05 04:03 (GMT+3)

GRD: JSC Grindeks enter into a supportive investment agreement which provides granting 1,5 mil Ls

2005.08.08, Grindeks, RIG
Grindeks                                                          08.08.2005

JSC Grindeks enter into a supportive investment agreement which provides
granting 1,5 millions of Ls from EU Development funds

On the 5th of August JSC Grindeks signed a contract with the Latvia Investment
and Development Agency (LIDA) which provides granting a supporting investment
of 1.5 millions of Ls from the EU Development funds. This sum of money is tailored
to development of the analytic scaling laboratory of Active pharmaceutical
ingredients. The total expenses of the project are estimated to amount to 3,26
millions of Ls.

The new scaling laboratory will comply with the requirements of the Good
Manufacturing Practice –cGMP (Current Good Manufacturing Practice), having a good
performance of all the devices and appliances and ensuring the quality of the
controlling process. The new laboratory will be fit for production of the active
pharmaceutical ingredients for industry and for clinical trials use.

The project will render to Latvian scientists the opportunity to perform a great
part of researches, including clinical trials, here in Latvia. The Institute of Organic
Synthesis (IOS), LTd Medpro, JSC Riga Pharmaceutical plant and JSC LMP are interested
in realization of this project as well.

This will be the first laboratory meeting the CGMP standards in the Baltic States.
It is planned to finish the construction of Active pharmaceutical ingredients analytic
scaling laboratory in May 2007.

Information prepared by:
Finance and Administrative director
JSC Grindeks
Office: 7083250,
GSM: 9226767
e-mail: janis_romanovskis@grindeks.lv

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai